Does SECUKINUMAB Cause Therapeutic response shortened? 1,097 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,097 reports of Therapeutic response shortened have been filed in association with SECUKINUMAB (COSENTYX). This represents 0.7% of all adverse event reports for SECUKINUMAB.
1,097
Reports of Therapeutic response shortened with SECUKINUMAB
0.7%
of all SECUKINUMAB reports
10
Deaths
79
Hospitalizations
How Dangerous Is Therapeutic response shortened From SECUKINUMAB?
Of the 1,097 reports, 10 (0.9%) resulted in death, 79 (7.2%) required hospitalization, and 12 (1.1%) were considered life-threatening.
Is Therapeutic response shortened Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SECUKINUMAB. However, 1,097 reports have been filed with the FAERS database.
What Other Side Effects Does SECUKINUMAB Cause?
Drug ineffective (27,434)
Psoriasis (21,976)
Pain (15,244)
Arthralgia (13,769)
Fatigue (9,406)
Psoriatic arthropathy (8,900)
Pruritus (8,755)
Malaise (8,570)
Rash (8,023)
Condition aggravated (7,536)
What Other Drugs Cause Therapeutic response shortened?
DUPILUMAB (6,720)
ADALIMUMAB (2,597)
INFLIXIMAB-DYYB (1,837)
INFLIXIMAB (1,231)
RISANKIZUMAB-RZAA (1,089)
CARBIDOPA\LEVODOPA (1,027)
ONABOTULINUMTOXINA (907)
ERENUMAB-AOOE (805)
CERTOLIZUMAB PEGOL (687)
NALTREXONE (658)
Which SECUKINUMAB Alternatives Have Lower Therapeutic response shortened Risk?
SECUKINUMAB vs SELADELPAR LYSINE
SECUKINUMAB vs SELEGILINE
SECUKINUMAB vs SELENIUM
SECUKINUMAB vs SELENIUM SULFIDE
SECUKINUMAB vs SELEXIPAG